Skip to main content

Table 4 ECHO findings in female HF types

From: Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit

   Mean P value
LVEDd (mm) HF-REF 39.07 ± 25 0.004
HF-PEF 17.53 ± 22  
LVESd (mm) HFrEF 23.84 ± 21 0.025
HFpEF 15.05 ± 20  
IVS (mm) HFrEF 5.42 ± 5 0.021
HFpEF 3.40 ± 4  
PWT (mm) HFrEF 5.36 ± 5 0.018
HFpEF 3.30 ± 4  
EF% HFrEF 33.88 ± 12 0.001
HFpEF 61.96 ± 12  
LA (mm) HFrEF 21.50 ± 19 0.012
HFpEF 12.87 ± 16  
AO (mm) HFrEF 28.26 ± 16.5 0.015
HFpEF 10.76 ± 15  
TAPSE (mm) HFrEF 6.84 ± 5.1 0.235
HFpEF 8.65 ± 4  
EPASP (mm) HFrEF 42.26 ± 13 0.503
HFpEF 40.12 ± 20  
E/A wave HFrEF 1.47 ± 1 0.409
HFpEF 1.67 ± 1  
E/e' wave HFrEF 18.31 ± 9.5 0.023
HFpEF 23.62 ± 12  
RWMA HFrEF 62 (85%) 0.002
HFpEF 27 (60%)  
  1. HFrEF heart failure with reduced ejection fraction, HFpEF heart failure with preserved ejection fraction, LVEDd left ventricular end diastolic diameter, LVESd left ventricular end systolic diameter, IVS interventricular thickness, PWT posterior wall thickness, EF% ejection fraction, LA left atrium, Ao aortic root diameter, TAPSE tricuspid annular plane systolic excursion, EPASP estimated pulmonary artery systolic pressure, E?A mitral flow early diastolic velocity, A mitral inflow atrial diastolic velocity, E/e mitral flow early diastolic velocityto early diastolic mitral annular velocity, RWMA regional wall motion abnormalities